Dr. Osman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3660 Vista Ave
Saint Louis, MO 63110Phone+1 314-577-8047Fax+1 314-268-5116
Education & Training
- Johns Hopkins University School of MedicineFellowship, PET/CT, 2001 - 2002
- Johns Hopkins UniversityResidency, Nuclear Medicine, 1999 - 2001
- University of Assiut Faculty of MedicineClass of 1985
Certifications & Licensure
- MO State Medical License 2002 - 2025
- IL State Medical License 2005 - 2014
- American Board of Nuclear Medicine Nuclear Medicine
Clinical Trials
- F18PET/CT Versus TC-MDP Scanning to Detect Bone Mets Start of enrollment: 2009 Jan 01
- A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD. Start of enrollment: 2011 Jun 01
- Prostate Cancer Patients With Biochemical Recurrence Start of enrollment: 2018 Dec 18
Publications & Presentations
PubMed
- 34 citationsPET‐CT and the detection of the asymptomatic recurrence or second primary lesions in the treated head and neck cancer patientKatherine A. Dunsky, Daniel Wehrmann, Medhat Osman, Brandon M. Thornberry, Mark A. Varvares
The Laryngoscope. 2013-09-01 - 46 citationsIs there a common SUV threshold in oncological FDG PET/CT, at least for some common indications? A retrospective study.Nghi Nguyen, Aarti Kaushik, Michael K. Wolverson, Medhat Osman
Acta Oncologica. 2011-05-16 - 165 citationsRespiratory motion artifacts on PET emission images obtained using CT attenuation correction on PET-CTMedhat Osman, Christian Cohade, Yuji Nakamoto, Richard L. Wahl
European Journal of Nuclear Medicine and Molecular Imaging. 2003-01-21
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: